SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 14 filers reported holding SUMMIT THERAPEUTICS PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,349,000 | -11.5% | 212,018 | 0.0% | 0.28% | -27.2% |
| Q3 2017 | $2,654,000 | +70.0% | 212,018 | +49.3% | 0.38% | +43.0% |
| Q2 2017 | $1,561,000 | -20.6% | 142,018 | -3.7% | 0.26% | -31.2% |
| Q1 2017 | $1,967,000 | +55.9% | 147,450 | 0.0% | 0.38% | +20.7% |
| Q4 2016 | $1,262,000 | -30.4% | 147,450 | -25.3% | 0.32% | +8.1% |
| Q3 2016 | $1,813,000 | +16.1% | 197,450 | 0.0% | 0.30% | -27.3% |
| Q2 2016 | $1,562,000 | +12.2% | 197,450 | -0.7% | 0.41% | +34.4% |
| Q1 2016 | $1,392,000 | -40.0% | 198,863 | -1.7% | 0.30% | -11.2% |
| Q4 2015 | $2,321,000 | +8.7% | 202,220 | -1.5% | 0.34% | +24.5% |
| Q3 2015 | $2,136,000 | -6.3% | 205,200 | 0.0% | 0.27% | +22.4% |
| Q2 2015 | $2,280,000 | +5.2% | 205,200 | +17.3% | 0.22% | -1.3% |
| Q1 2015 | $2,168,000 | – | 175,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 212,018 | $2,349,000 | 0.28% |
| Granite Point Capital Management, L.P. | 242,113 | $2,683,000 | 0.26% |
| LANSDOWNE PARTNERS (UK) LLP | 1,596,666 | $17,691,000 | 0.16% |
| Point72 Asset Management, L.P. | 785,600 | $8,704,000 | 0.04% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 80,000 | $886,000 | 0.02% |
| AXA S.A. | 282,760 | $3,133,000 | 0.01% |
| Polar Capital LLP | 100,000 | $1,108,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 144,083 | $1,595,000 | 0.01% |
| First Eagle Investment Management, LLC | 194,900 | $2,159,000 | 0.01% |
| Alyeska Investment Group, L.P. | 50,000 | $554,000 | 0.00% |